Jun Wang

Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant

Jianxiang Wang, Wei Liu, L. Qiu, 2022, Annals of Hematology.

The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.

K. Ru, Jianxiang Wang, Chenwei Li, 2015, American journal of clinical pathology.

Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM

Jianxiang Wang, Wei Liu, L. Qiu, 2022, Blood advances.

The Significance of Bone Marrow Involvement in Aggressive Lymphomas: A Retrospective Comparison of Clinical Outcomes between Peripheral T Cell Lymphoma and Diffuse Large B Cell Lymphoma in China

L. Qiu, G. An, Yao-zhong Zhao, 2010, Acta Haematologica.

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma

E. Giné, E. Campo, S. Beà, 2021, The Journal of clinical investigation.

Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant

Jianxiang Wang, Wei Liu, L. Qiu, 2022, Annals of Hematology.

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma

Jianxiang Wang, L. Qiu, G. An, 2022, Blood science.

High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia

R. Gale, Jianxiang Wang, T. Cheng, 2021, Leukemia.